| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/11/2001 | EP0735819B1 Cryptophycins |
| 07/11/2001 | EP0731808B1 Nucleosides and oligonucleotides containing boron clusters |
| 07/11/2001 | EP0683783B1 Rapamycin derivative process for its preparation and its use |
| 07/11/2001 | CN1303442A Method |
| 07/11/2001 | CN1303436A Compositions and methods for sensitizing and inhibiting growth of human tumor cells |
| 07/11/2001 | CN1303435A TAO protein kinases and methods of use therefor |
| 07/11/2001 | CN1303430A FAP alpha specific antibody with improved producibility |
| 07/11/2001 | CN1303429A Therapeutic applications of mature FLINT (mFLINT) polypeptides or OPG3, member of TNF receptor superfamily |
| 07/11/2001 | CN1303393A Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 07/11/2001 | CN1303391A 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/11/2001 | CN1303388A Platinum complex, its preparation and therapeutic application |
| 07/11/2001 | CN1303387A Platinum complex, its preparation and therapeutic application |
| 07/11/2001 | CN1303380A Isothizole derivatives useful anticancer agents |
| 07/11/2001 | CN1303379A 2-Aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 07/11/2001 | CN1303374A Substituted indolinones, production thereof and their use as medicaments |
| 07/11/2001 | CN1303372A New heterocyclically substituted amides, their production and their use |
| 07/11/2001 | CN1303368A 1 Alpha-hydroxy-25-ene-vitamin D, analogs and use thereof |
| 07/11/2001 | CN1303300A Isolated peptides corresponding to amino acid sequences of NY-ESO-1, wherein bind to MHC class I and MHC class II molecules, and uses thereof |
| 07/11/2001 | CN1303297A Treatment of arthritis and other similar conditions |
| 07/11/2001 | CN1303294A Antitumor agents |
| 07/11/2001 | CN1303293A Process for producing composite preparation containing nucleic acid |
| 07/11/2001 | CN1303289A Adenosine A3 receptor modulators |
| 07/11/2001 | CN1303288A Combination therapy for treatment of tumors |
| 07/11/2001 | CN1303269A Anticancer compositions |
| 07/11/2001 | CN1302888A Polypeptide-human rigor factor 23 and polynucleotide for coding it |
| 07/11/2001 | CN1302804A Dihydrofuro [3,4-b] quinoline-1-ketone type compound, its preparation method and medicinal composition containing these compounds |
| 07/11/2001 | CN1302657A Medicine for induction-differential therapy and its application |
| 07/11/2001 | CN1302650A 'Hehe' ointment and its preparing process |
| 07/11/2001 | CN1302627A Anticancer sal ammoniac capsule |
| 07/11/2001 | CN1302622A Moxaburning medicine as Chinese patent one for treating cancer |
| 07/11/2001 | CN1302619A Process for preparing exterior-applied medicine to prevent and cure cancers |
| 07/11/2001 | CN1302617A Process for preparing instant particles to prevent and cure cancers |
| 07/11/2001 | CN1302613A Compound pancreatic ribonucleate for injection |
| 07/11/2001 | CN1302609A Phosphonate medicine for treating osteoporosis and bone cancer transfer |
| 07/11/2001 | CN1302559A Curcumin preparation |
| 07/11/2001 | CN1068335C Novel anti-neoplastic cytokine |
| 07/11/2001 | CN1068200C 9-cis-isotretinoin and use of its salt and ester medicine |
| 07/11/2001 | CN1068199C Anti-cancer microballs and manufacturing method thereof |
| 07/10/2001 | WO2001051056A1 Fulvestrant formulation |
| 07/10/2001 | US6258952 Thermally stable trimetrexates and processes for producing the same |
| 07/10/2001 | US6258951 Chemical compounds |
| 07/10/2001 | US6258948 An n-acylamino compound; antiinflammatory agents, autoimmune diseases |
| 07/10/2001 | US6258851 Metalloproteinase inhibitors |
| 07/10/2001 | US6258849 Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate |
| 07/10/2001 | US6258845 Cancer treatment and antiinflammatory agents |
| 07/10/2001 | US6258833 Enzyme inhibitors and antiinflammatory agents |
| 07/10/2001 | US6258831 Viral treatment |
| 07/10/2001 | US6258824 Treatment of hyperproliferative diseases, such as cancers, in mammals. this invention also relates to a pharmaceutical compositions containing such compounds. |
| 07/10/2001 | US6258820 Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines |
| 07/10/2001 | US6258817 Substituted pyrazin-2-yl-sulphonamide (-3-pyridyl) compounds and uses thereof |
| 07/10/2001 | US6258812 Phthalazines with angiogenesis inhibiting activity |
| 07/10/2001 | US6258790 Antisense modulation of integrin α4 expression |
| 07/10/2001 | US6258786 Antitumor agents of anthracycline glycosides |
| 07/10/2001 | US6258775 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses |
| 07/10/2001 | US6258600 Antisense modulation of caspase 8 expression |
| 07/10/2001 | US6258598 EBV-infected stomach cancer cell line |
| 07/10/2001 | US6258562 Human antibodies that bind human TNFα |
| 07/10/2001 | US6258357 Extracting allogeneic human donor blood aliquot; separating t-cells; oxidatingstressing to reduce cytokines; administering to patient undergoing bone marrow transplant |
| 07/10/2001 | US6258338 Comprising beta-emitting radionuclide of yttria used in internal radiation therapy of cancer and tumors of the liver |
| 07/10/2001 | US6258121 Stent coating |
| 07/10/2001 | CA2175643C Utilization of retinoids in a cosmetic composition or in the preparation of a pharmaceutical composition |
| 07/05/2001 | WO2001048485A2 Selecting library members capable of binding to epitopes |
| 07/05/2001 | WO2001048238A2 Chemotherapeutant screening method |
| 07/05/2001 | WO2001048233A1 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 07/05/2001 | WO2001048203A1 Novel protein and dna thereof |
| 07/05/2001 | WO2001048190A2 Therapeutic uses of lna-modified oligonucleotides |
| 07/05/2001 | WO2001048187A2 A molecular switch for regulating mammalian gene expression |
| 07/05/2001 | WO2001048163A2 Dioxygenases catalyzing the asymetric cleavage of beta-carotene |
| 07/05/2001 | WO2001048162A2 Method for the production of vitamin a |
| 07/05/2001 | WO2001048161A2 Human heparanase-related polypeptide and nucleic acid |
| 07/05/2001 | WO2001048154A1 Maturation-promoting agent for immature dendritic cells |
| 07/05/2001 | WO2001048012A1 A new polypeptide- nadh dehydrogenase subunit i-11 and the polynucleotide encoding it |
| 07/05/2001 | WO2001048011A1 A new polypeptide- small hydrophilic plant seed protein 10 and the polynucleotide encoding it |
| 07/05/2001 | WO2001048007A1 A new polypeptide-clathrin 12 and the polynucleotide encoding it |
| 07/05/2001 | WO2001048004A1 A new polypeptide-heparin bind protein 10 and the polynucleotide encoding it |
| 07/05/2001 | WO2001048003A1 A new polypeptide-amyloid gylcoprotein 10 and the polynucleotide encoding it |
| 07/05/2001 | WO2001048002A1 A new polypeptide - cytochrome b12 and the polynucleotide encoding it |
| 07/05/2001 | WO2001047999A1 A new polypeptide-human gonadoliberin 11 and the polynucleotide encoding it |
| 07/05/2001 | WO2001047997A1 A new polypeptide-stathmin protein 8 and the polynucleotide encoding it |
| 07/05/2001 | WO2001047986A1 A new polypeptide-thiolase protein 11 and the polynucleotide encoding it |
| 07/05/2001 | WO2001047960A1 Uses of transport proteins for controlling cell cycle |
| 07/05/2001 | WO2001047959A2 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 07/05/2001 | WO2001047953A2 Antibodies against plasma cells |
| 07/05/2001 | WO2001047950A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 07/05/2001 | WO2001047946A2 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 07/05/2001 | WO2001047930A1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof |
| 07/05/2001 | WO2001047922A2 Azaindoles |
| 07/05/2001 | WO2001047921A1 Pyrimidine and triazine kinase inhibitors |
| 07/05/2001 | WO2001047920A1 Benzazole derivatives and their use as jnk modulators |
| 07/05/2001 | WO2001047919A1 Substituted oxazolidinones and their use in the field of blood coagulation |
| 07/05/2001 | WO2001047916A1 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity |
| 07/05/2001 | WO2001047915A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047914A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047913A2 Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect |
| 07/05/2001 | WO2001047905A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047899A1 Substituted piperazine derivatives as mtp inhibitors |
| 07/05/2001 | WO2001047897A1 Cytokine, especially tnf-alpha, inhibitors |
| 07/05/2001 | WO2001047892A1 Tricyclic protein kinase inhibitors |
| 07/05/2001 | WO2001047891A1 Heterocyclic compounds having sulfonamide groups |
| 07/05/2001 | WO2001047886A1 Nitrile derivatives as cathepsin k inhibitors |